Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial. [electronic resource]
Producer: 20180213Description: 189-196 p. digitalISSN:- 1464-5491
- Aged
- Blood Glucose -- metabolism
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Drug Combinations
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- therapeutic use
- Insulin, Long-Acting -- therapeutic use
- Liraglutide -- therapeutic use
- Male
- Metformin -- therapeutic use
- Middle Aged
- Sulfonylurea Compounds -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.